GlycoMimetics Inc (GLYC)
0.2716
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.2711
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Price to Book Value: 0.6057 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.6057 |
| May 30, 2024 | 0.611 |
| May 29, 2024 | 0.5719 |
| May 28, 2024 | 0.5954 |
| May 24, 2024 | 0.602 |
| May 23, 2024 | 0.6092 |
| May 22, 2024 | 0.6295 |
| May 21, 2024 | 0.6141 |
| May 20, 2024 | 0.6442 |
| May 17, 2024 | 0.6676 |
| May 16, 2024 | 0.6268 |
| May 15, 2024 | 0.602 |
| May 14, 2024 | 0.6154 |
| May 13, 2024 | 0.5851 |
| May 10, 2024 | 0.5945 |
| May 09, 2024 | 0.6645 |
| May 08, 2024 | 0.6654 |
| May 07, 2024 | 0.681 |
| May 06, 2024 | 0.7033 |
| May 03, 2024 | 4.080 |
| May 02, 2024 | 3.834 |
| May 01, 2024 | 3.612 |
| April 30, 2024 | 4.013 |
| April 29, 2024 | 3.455 |
| April 26, 2024 | 3.656 |
| Date | Value |
|---|---|
| April 25, 2024 | 3.812 |
| April 24, 2024 | 4.135 |
| April 23, 2024 | 4.091 |
| April 22, 2024 | 4.013 |
| April 19, 2024 | 4.291 |
| April 18, 2024 | 4.815 |
| April 17, 2024 | 5.083 |
| April 16, 2024 | 4.793 |
| April 15, 2024 | 5.027 |
| April 12, 2024 | 5.350 |
| April 11, 2024 | 5.584 |
| April 10, 2024 | 5.462 |
| April 09, 2024 | 5.974 |
| April 08, 2024 | 5.774 |
| April 05, 2024 | 6.131 |
| April 04, 2024 | 6.041 |
| April 03, 2024 | 6.164 |
| April 02, 2024 | 6.599 |
| April 01, 2024 | 6.777 |
| March 28, 2024 | 5.033 |
| March 27, 2024 | 5.335 |
| March 26, 2024 | 4.782 |
| March 25, 2024 | 4.731 |
| March 22, 2024 | 4.916 |
| March 21, 2024 | 4.832 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Jun 16 2022
6.777
Maximum
Apr 01 2024
1.587
Average
1.212
Median
Oct 18 2019
Price to Book Value Benchmarks
| Altimmune Inc | 3.079 |
| Lyell Immunopharma Inc | 1.171 |
| Amicus Therapeutics Inc | 22.21 |
| InfuSystems Holdings Inc | 2.909 |
| Nanoviricides Inc | 2.662 |
Price to Book Value Related Metrics
| Price | 0.2716 |
| Earnings Yield | -213.5% |
| Market Cap | 17.51M |